Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-388
Closed -$62K 223
2022
Q2
$62K Buy
388
+18
+5% +$4.26K 0.01% 196
2022
Q1
$138K Buy
370
+301
+436% +$102K 0.02% 191
2021
Q4
$27K Buy
69
+6
+10% +$3.49K ﹤0.01% 219
2021
Q3
$47K Sell
63
-535
-89% -$448K 0.01% 257
2021
Q2
$624K Buy
598
+150
+33% +$179K 0.1% 172
2021
Q1
$668K Buy
448
+311
+227% +$452K 0.12% 166
2020
Q4
$145K Buy
137
+77
+128% +$70K 0.03% 225
2020
Q3
$43K Buy
60
+14
+30% +$13.4K 0.01% 194
2020
Q2
$31K Buy
46
+16
+53% +$7.18K 0.01% 188
2020
Q1
$10K Buy
+30
New +$11.8K ﹤0.01% 140

Other funds holding YCBD

IQ EQ Fund Management's YCBD Position: Q3 2022 in Review

IQ EQ Fund Management sold out of cbdMD (YCBD) in Q3 2022, closing a stake of 388 shares — an estimated $62K sold.

IQ EQ Fund Management first reported a position in YCBD in Q1 2020 and held it in 10 quarters. The position peaked at $668K in Q1 2021. 46 funds tracked by Wall St. Rank hold YCBD as of Q3 2022.

  • IQ EQ Fund Management reported no remaining cbdMD position as of Q3 2022 after selling out during the quarter.
  • IQ EQ Fund Management sold 388 cbdMD shares in Q3 2022, an estimated $62K.
  • IQ EQ Fund Management first reported a position in cbdMD in Q1 2020 and held it in 10 quarters.
  • IQ EQ Fund Management's cbdMD position peaked at $668K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held cbdMD as of Q3 2022.

Based on IQ EQ Fund Management's 13F filing for Q3 2022, filed 26 Oct 2022.